Ozempic Face: Causes, Prevention, and How to Manage

"Ozempic face" is a colloquial term for facial volume loss observed in some patients during rapid weight loss with GLP-1 medications. The phenomenon has been widely discussed in popular media, but is frequently misunderstood. This article explains what it is, who is affected, and what the evidence says about prevention.

What is "Ozempic face"?

Ozempic face describes the gaunt, hollowed, or aged appearance some patients develop in the cheeks, temples, and around the eyes during significant weight loss. It is not caused by semaglutide directly — rather, it is a consequence of rapid loss of subcutaneous and deep facial fat that occurs alongside body fat loss.

Similar changes occur with any rapid weight loss regimen — bariatric surgery, very-low-calorie diets, intense intermittent fasting. The visibility of these changes with GLP-1 medications is partly because patients are losing significant weight (often 15-25%+) over relatively short periods.

Who is most at risk?

• Patients over 40, where facial fat depots are thinner to begin with
• Patients losing >20% of starting body weight
• Patients with already lean baseline body composition
• Patients with rapid weight loss (>1.5 kg/week)

Evidence-based prevention strategies

No medication or intervention has been proven to specifically prevent Ozempic face during GLP-1 treatment. However, general strategies that preserve facial volume during weight loss have evidence behind them:

• Slower weight loss rate (1-2 lbs/week target) — discuss dose adjustments with your prescriber
• Adequate protein intake (>1g/kg body weight) preserves lean mass including facial muscle
• Resistance training preserves overall lean tissue
• Adequate hydration and electrolytes maintain skin turgor
• Skin-care including SPF protects collagen integrity

Cosmetic interventions

For patients with significant facial volume loss after GLP-1 weight loss, dermatologists can use injectable dermal fillers (hyaluronic acid-based) or biostimulatory agents (poly-L-lactic acid) to restore midface and temple volume. These are typically not covered by insurance.

When to consult a clinician

If facial changes are bothering you, talk to your prescribing provider about slowing weight loss rate or pausing dose escalation. For cosmetic concerns, a board-certified dermatologist or facial plastic surgeon can advise on restorative options.

Bottom line

Ozempic face is real, but it is not caused by the drug — it is caused by the weight loss the drug enables. Prevention strategies center on slowing weight loss rate, preserving lean mass through protein and resistance training, and skin care. If you have concerns, your prescriber and a dermatologist are the right resources.